26.10.2018
- East Rutherford, NJ/USA-based Cambrex Corporation is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its...
19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
25.07.2018
- Cambrex, a US-based small molecule innovator and developer of generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire compatriot Contract Development and...
02.10.2017
- Does the consolidation in the pharmaceutical industry affect CROs/CMOs, e.g. does it create a necessity for outsourcing partners to consolidate, too? Simon Edwards: It is somewhat...
28.09.2017
- Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...
14.08.2017
- Cambrex Corporation, a US manufacturer of active pharmaceutical ingredients (APIs) has announced another expansion to boost its global network. This latest project will see an...
09.06.2017
- US active pharmaceutical ingredients (API) manufacturer Cambrex Corporation has announced the expansion of large-scale manufacturing capacity at its cGMP plant in Karlskoga, Sweden...
